Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Theodore R. Schroeder currently holds 20,500 shares of Nabriva Therapeutics plc (NBRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Theodore R. Schroeder has been a net seller of NBRV stock. They have purchased $322.7K and sold $1.7M worth of shares.
Theodore R. Schroeder's most recent insider trade was on Dec 17, 2024, when they sold 20,500 shares at $0.00 per share.
Theodore R. Schroeder serves as Executive at Nabriva Therapeutics plc (NBRV). They have executed 92 insider transactions totaling $2.1M over their tenure at the company.
Theodore R. Schroeder holds the position of Executive at Nabriva Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Theodore R. Schroeder has shown a selling trading pattern, with $322.7K in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Theodore R. Schroeder was on Dec 28, 2021, when they purchased $57.0K worth of NBRV shares. This transaction involved 100,000 shares at $0.57 per share.
Theodore R. Schroeder currently owns 20,500 shares of Nabriva Therapeutics plc (NBRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Theodore R. Schroeder's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Theodore R. Schroeder has 92 Form 4 filings on record as an insider at Nabriva Therapeutics plc.
Set alerts for Theodore R. Schroeder and 40,000+ other insiders.